Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients

Abstract Enhanced oxidative stress partly resulting from an over-production of superoxide anion (O2•−) represents a novel and particular risk factor in chronic kidney disease (CKD) patients. This study was therefore designed to evaluate O2•− determinants in this population. O2•− production was evaluated using chemiluminescence method in 136 CKD patients (79M/57F, median age: 69.5 [27.4–94.6]). Renal function (evaluated by the glomerular filtration rate using modification of diet in renal disease (MDRD)), inflammation, lipids, nutritional and bone mineral as well as clinical parameters were evaluated. Potential relationships between O2•− and these clinico-biological parameters were investigated to identify main determinants of such a pathological process. Enhanced O2•− production has been observed at the pre-dialysis phase: stages 4 and 5 of CKD (p = 0.0065). In multivariate analysis, low eGFR (MDRD <30 mL/min/1.73 m2; p = 0.046), high fibrinogen (≥3.7 g/L; p = 0.044) and abnormal HDL cholesterol (<1.42 mmol/L and ≥ 1.75 mmol/L; p = 0.042) were the main determinants of O2•− production in CKD patients.

[1]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[2]  A. Goux,et al.  NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia , 2011, Free radical research.

[3]  Z. Massy,et al.  PROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease , 2009, Seminars in dialysis.

[4]  M. Picot,et al.  Homocysteine and inflammation as main determinants of oxidative stress in the elderly. , 2009, Free radical biology & medicine.

[5]  S. Reese,et al.  Nox‐2 Is a Modulator of Fibrogenesis in Kidney Allografts , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  A. Jurek,et al.  The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients. , 2008, Clinical biochemistry.

[7]  J. Cristol,et al.  Regional Variations of Low-Density Lipoprotein Oxidizability in Hemodialysis Patients May Explain Discrepancies in Interventional Therapy on Oxidative Profile , 2008, Blood Purification.

[8]  D. Grekas,et al.  Increase in Oxidative Stress but Not in Antioxidant Capacity with Advancing Stages of Chronic Kidney Disease , 2007, American Journal of Nephrology.

[9]  R. Natarajan,et al.  Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes , 2007, Diabetes.

[10]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[11]  L. Carbone,et al.  Oxidative stress in aldosteronism. , 2006, Cardiovascular research.

[12]  C Zoccali,et al.  Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. , 2006, Kidney international.

[13]  N. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. , 2006, American journal of physiology. Renal physiology.

[14]  Helmut Acker,et al.  The oxygen sensing signal cascade under the influence of reactive oxygen species , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[15]  K. Rosenblatt,et al.  Regulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦ , 2005, Journal of Biological Chemistry.

[16]  Y. Sasaguri,et al.  Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits , 2005, Circulation.

[17]  T. Hosoya,et al.  Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. , 2004, Kidney international.

[18]  K. Prasad C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils , 2004, Journal of cardiovascular pharmacology and therapeutics.

[19]  J. Morrow,et al.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.

[20]  M. Landray,et al.  Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  D. Stengel,et al.  Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis , 2003, Circulation.

[22]  Gabor Kaley,et al.  Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia: Role of Tumor Necrosis Factor-&agr;, NAD(P)H Oxidase, and Inducible Nitric Oxide Synthase , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[23]  M. Goolsby National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, Journal of the American Academy of Nurse Practitioners.

[24]  J. Gamble,et al.  Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. , 2001, Atherosclerosis.

[25]  D. Shih,et al.  The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.

[26]  S. Friedman,et al.  Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. , 2001, American journal of physiology. Endocrinology and metabolism.

[27]  J. Himmelfarb,et al.  Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. , 2000, Kidney international.

[28]  S. Reddy,et al.  Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.

[29]  G. Lonnemann Chronic Inflammation in Hemodialysis: The Role of Contaminated Dialysate , 2000, Blood Purification.

[30]  D. Tarng,et al.  Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. , 2000, Kidney international.

[31]  T. Dantoine,et al.  Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  S. Liou,et al.  Increase in Resting Levels of Superoxide Anion in the Whole Blood of Uremic Patients on Chronic Hemodialysis , 1998, Blood Purification.

[33]  P. Jungers,et al.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.

[34]  I. Young,et al.  Oxidative stress in chronic renal failure. , 1998, Free radical research.

[35]  H. Lander An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  P. Jungers,et al.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.

[37]  D. Stafforini,et al.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. , 1995, The Journal of clinical investigation.

[38]  K. Mcleish,et al.  Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. , 1995, Journal of the American Society of Nephrology : JASN.

[39]  P. McNamee,et al.  Oxidative stress in haemodialysis. , 1994, QJM : monthly journal of the Association of Physicians.

[40]  R. Gans,et al.  C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. , 2004, Atherosclerosis.

[41]  B. Descomps,et al.  Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the olympus analyzer , 2003, Journal of clinical laboratory analysis.

[42]  L Guize,et al.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.

[43]  J. Castel,et al.  [Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach?]. , 1997, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[44]  S Greenland,et al.  The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.